Bookbot

Dienogest

Präklinik und Klinik eines Gestagens - 2. Auflage

Więcej o książce

This comprehensive work explores the pharmacology and toxicology of Dienogest, detailing its chemical structure and experimental endocrinological studies. It examines the hormonal effects of Dienogest in cellular test systems and investigates its pharmacokinetics and biotransformation across various animal species, as well as by microorganisms. The pharmacological and toxicological profile is assessed, including its initiating efficacy in bioassays and studies conducted on primates. The clinical section focuses on the pharmacokinetics of Dienogest, both as a standalone treatment and in combination with Ethinylestradiol. It includes binding studies with various receptor and serum proteins, the impact of Dienogest on calcium influx in human vascular cell cultures, and its influence on the human cytochrome P-450 enzyme system. Comparative studies evaluate the effects of Ethinylestradiol-containing contraceptives with Dienogest versus Levonorgestrel on cytochrome P-450 function in vivo. Further investigations cover Dienogest's effects on ovulation and other endocrine parameters in young women, alongside pilot studies on contraceptive safety, cycle stability, and tolerability. Long-term studies assess the impact of various contraceptives on women's vocal function and document the antiandrogenic effects of Dienogest. The treatment of endometriosis with Dienogest is also discussed, highlighting its receptor status and the renaissan

Zakup książki

Dienogest, Alexander T. Teichmann

Język
Rok wydania
1995
Oprawa
(twarda),
Stan książki
Dobry
Cena
4,12 zł

Metody płatności

Nikt jeszcze nie ocenił.Oceń

Tytuł
Dienogest
Podtytuł
Präklinik und Klinik eines Gestagens - 2. Auflage
Język
niemiecki
Wydawca
De Gruyter
Rok wydania
1995
Oprawa
twarda
Liczba stron
292
ISBN10
3110150859
ISBN13
9783110150858
Seria
Opis
This comprehensive work explores the pharmacology and toxicology of Dienogest, detailing its chemical structure and experimental endocrinological studies. It examines the hormonal effects of Dienogest in cellular test systems and investigates its pharmacokinetics and biotransformation across various animal species, as well as by microorganisms. The pharmacological and toxicological profile is assessed, including its initiating efficacy in bioassays and studies conducted on primates. The clinical section focuses on the pharmacokinetics of Dienogest, both as a standalone treatment and in combination with Ethinylestradiol. It includes binding studies with various receptor and serum proteins, the impact of Dienogest on calcium influx in human vascular cell cultures, and its influence on the human cytochrome P-450 enzyme system. Comparative studies evaluate the effects of Ethinylestradiol-containing contraceptives with Dienogest versus Levonorgestrel on cytochrome P-450 function in vivo. Further investigations cover Dienogest's effects on ovulation and other endocrine parameters in young women, alongside pilot studies on contraceptive safety, cycle stability, and tolerability. Long-term studies assess the impact of various contraceptives on women's vocal function and document the antiandrogenic effects of Dienogest. The treatment of endometriosis with Dienogest is also discussed, highlighting its receptor status and the renaissan